Reveal Biosciences Inc.
- UEI
- HEEAZ9FXXM13
- CAGE
- 6TK86
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- cellcarta.com
- Founded
- 2000
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Antibody procurement/h & e (tissue to imaging, no analysis)/ massons trichrome (blocks to imaging, no analysis)/ plex… | Bureau of Medicine and Surgery | $30,420 | |
| Topic #411 - phase i sbir contract - an imagedx based platform for comprehensive DE-identification of WSI data | National Cancer Institute | $370,804 | |
| Sbir phase i topic 402: artificial intelligence-aided imaging for cancer prevention, diagnosis, and monitoring | National Cancer Institute | $392,343 | |
| Sbir solicitation no. PHS 2020-1 topic #408: tools and technologies for visualizing multi-scale data project title: an… | National Cancer Institute | $386,940 | |
| ENT department research team requires a lab that can perform immunohistochemistry stain with antibodies to collagen i… | Bureau of Medicine and Surgery | $13,545 |
About Reveal Biosciences Inc.
Reveal Biosciences Inc. is a computational pathology company that provides advanced tissue analysis technologies and artificial intelligence-enabled imaging platforms for cancer research and diagnosis. The company combines traditional histopathology with AI to transform tissue into actionable data.
Reveal Biosciences has been awarded multiple federal contracts from HHS agencies like NIH and NCI to develop AI and imaging platforms to support cancer research and prevention efforts. This includes SBIR contracts to build tools for visualizing multi-scale cancer data across tissue, cellular, molecular, and genomic levels. Reveal has also received contracts for comprehensive de-identification of whole slide imaging data to enable broader research use, as well as for novel AI-aided imaging approaches for cancer screening and monitoring. Additionally, Reveal has provided specialized immunohistochemistry services for Navy medical research. The contract awards have generally been firm-fixed price vehicles with Reveal Biosciences as the prime contractor. Most have involved total small business set-asides.
Quick answers
What is Reveal Biosciences Inc.'s UEI?
Reveal Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is HEEAZ9FXXM13.
What is Reveal Biosciences Inc.'s CAGE code?
Reveal Biosciences Inc.'s CAGE code is 6TK86.
What is Reveal Biosciences Inc.'s primary NAICS code?
Reveal Biosciences Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Reveal Biosciences Inc. registered in SAM.gov?
Reveal Biosciences Inc.'s SAM.gov registration expired on July 23, 2024.
What is Reveal Biosciences Inc.'s most recent federal award?
Reveal Biosciences Inc.'s most recent federal contract award is Antibody procurement/h & e (tissue to imaging, no analysis)/ massons trichrome (blocks to imaging, no analysis)/ plex… (N0025922P0201), from Bureau of Medicine and Surgery, on July 13, 2022.
On GovTribe
See Reveal Biosciences Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors